Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
post-crizotinib
.
Show all posts
Showing posts with label
post-crizotinib
.
Show all posts
Thursday, September 3, 2015
Brigatinib drug shows promise against ALK non-small cell lung cancer in phase I/II clinical trial
›
Phase I/II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising r...
›
Home
View web version
